Health
Therapy
Biotechnology

CRISPR

29,411

$41.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.17 (-4.93%) Today
-$0.32 (-0.77%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CRISPR and other stocks, options, ETFs, and crypto commission-free!

About CRSP

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. Read More The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

CEO
Samarth Kulkarni
Employees
304
Headquarters
Zug, Zug
Founded
2014
Market Cap
2.54B
Price-Earnings Ratio
35.61
Dividend Yield
—
Average Volume
940.30K
High Today
$43.36
Low Today
$40.93
Open Price
$42.55
Volume
580.66K
52 Week High
$74.00
52 Week Low
$32.30

Collections

Health
Therapy
Biotechnology
Medical
Technology
2016 IPO

CRSP Earnings

-$1.07
$0.09
$1.24
$2.40
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 27, After Hours

People Also Bought

Editas Medicine

10,243

$19.96

-4.95%

Editas Medicine

10,243

$19.96

-4.95%

Intellia Therapeutics

5,173

$11.90

-10.59%

Sangamo Therapeutics

7,534

$6.50

-2.40%

Canopy Growth

190,961

$14.55

-4.02%

You May Also Like

SBE=
BACHY
HYDB
AVGOP
HSII
DWT
ECOW
WWW
LIFE
HUYA
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CRSP

Market Price$41.50
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell CRISPR stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up